Close Menu

NEW YORK — Thermo Fisher Scientific said on Monday that it has received CE marking for its EliA SARS-CoV-2-Sp1 IgG test and its OmniPath COVID-19 Total Antibody ELISA Test for SARS-CoV-2.

The EliA SARS-CoV-2-Sp1 IgG test is designed for the quantitative detection of immunoglobulin G against the virus. It runs on Thermo Fisher's Phadia 250 instrument, which the company said can process up to 60 results per hour.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.